STOCK TITAN

GeoVax Labs (GOVX): Armistice Capital and Steven Boyd disclose 4.99% stake

(Moderate)
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

GeoVax Labs, Inc. is reported to have 387,038 shares of its common stock beneficially owned by Armistice Capital, LLC and Steven Boyd, representing 4.99% of the outstanding class as of June 30, 2026. All of these shares are held with shared voting and dispositive power; neither reporting person has sole voting or dispositive authority. Armistice Capital serves as investment manager to Armistice Capital Master Fund Ltd., the direct holder of the shares, and may be deemed to beneficially own the securities held by the Master Fund. Steven Boyd, as managing member of Armistice Capital, may also be deemed a beneficial owner, while the Master Fund has the right to receive dividends and sale proceeds.

Positive

  • None.

Negative

  • None.
Shares beneficially owned 387,038 shares Common stock of GeoVax Labs, Inc. reported by Armistice Capital and Steven Boyd
Percent of class 4.99% Portion of GeoVax Labs, Inc. common stock outstanding as of June 30, 2026
Shared voting power 387,038 shares Shares over which the reporting persons have shared power to vote or direct the vote
Shared dispositive power 387,038 shares Shares over which the reporting persons have shared power to dispose or direct disposition
As-of date 06/30/2026 Date as of which the beneficial ownership information is reported
beneficially own financial
"may be deemed to beneficially own the securities of the Issuer held by the Master Fund"
Beneficially own means having the economic rights and risks of a security—such as the right to receive dividends, sell the shares, or profit from price changes—whether or not your name appears on the official share register. Think of it like renting a car: you use it and reap the benefits even if the title lists someone else. Investors care because beneficial ownership determines who truly controls value, must be disclosed under securities rules, and can signal potential influence or trading activity that affects a stock’s price.
Investment Management Agreement financial
"pursuant to an Investment Management Agreement, Armistice Capital exercises voting and investment power"
An investment management agreement is a written contract that hires a professional to make buying, selling and strategy decisions for an investment account or fund, and sets out their duties, fees, risk limits, performance measures and reporting requirements. It matters to investors because the agreement determines who controls the money, how much the service costs, what risks are allowed, and how success or failure is measured—think of it as the service contract that defines expectations and remedies for a hired portfolio manager.
shared voting power financial
"Shared Voting Power 387,038.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
shared dispositive power financial
"Shared Dispositive Power 387,038.00"
Schedule 13G regulatory
"JOINT FILING STATEMENT PURSUANT TO RULE 13d-1(k)"
A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.

FAQ

What stake in GeoVax Labs, Inc. (GOVX) does Armistice Capital report in this Schedule 13G/A?

Armistice Capital and Steven Boyd report beneficial ownership of 387,038 shares of GeoVax Labs common stock, representing 4.99% of the outstanding class as of June 30, 2026.

Who are the reporting persons in the GeoVax Labs (GOVX) Schedule 13G/A Amendment No. 4?

The reporting persons are Armistice Capital, LLC and Steven Boyd. Armistice is the investment manager to Armistice Capital Master Fund Ltd., and Boyd is Armistice’s managing member, so each may be deemed to beneficially own the reported shares.

What voting and dispositive powers over GeoVax (GOVX) shares are disclosed by Armistice Capital?

The filing shows 0 shares with sole voting or dispositive power and 387,038 shares with shared voting and shared dispositive power. All reported authority is therefore shared, not sole.

Why does the filing state ownership of 5 percent or less of GeoVax (GOVX) stock?

The reporting persons state beneficial ownership of 4.99% of the class, which falls under the “Ownership of 5 percent or less of a class” category. This signals their position is below the 5% threshold.

What role does Armistice Capital Master Fund Ltd. have in the GeoVax (GOVX) position?

Armistice Capital Master Fund Ltd. is the direct holder of the shares and has the right to receive dividends and sale proceeds. Armistice Capital manages the Master Fund’s investments under an Investment Management Agreement.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates





373678705

(CUSIP Number)
06/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Armistice Capital, LLC
Signature:/s/ Steven Boyd
Name/Title:Steven Boyd - Managing Member
Date:08/14/2026
Steven Boyd
Signature:/s/ Steven Boyd
Name/Title:Steven Boyd
Date:08/14/2026
Exhibit Information

JOINT FILING STATEMENT PURSUANT TO RULE 13d-1(k) The undersigned acknowledge and agree that the foregoing statement on Schedule 13G, is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13G, shall be filed on behalf of each of the undersigned without the necessity of filing additional joint acquisition statements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him or it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that he or it knows or has reason to believe that such information is inaccurate. Dated: August 14, 2026 Armistice Capital, LLC By: /s/ Steven Boyd Steven Boyd - Managing Member Steven Boyd By: /s/ Steven Boyd